- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
有加速下跌的趋势。
- 长期趋势：
已有57家主力机构披露2025-12-31报告期持股数据，持仓量总计438.07万股，占流通A股3.05%
- 波段诊断：
-
技术面诊股
诊断结果：2.3技术面打败了8%的股票
技术面评分前10的股票
近期的平均成本为9.95元。空头行情中，并且有加速下跌的趋势。
平均成本
近期的平均成本为9.95元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"9.95","date":1780473881,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，跑输行业平均水平。
[{"date":"2026.06.04","stock":"-1.88","trade":null,"ind":"-0.27"},{"date":"2026.06.03","stock":"-1.56","trade":null,"ind":"0.73"},{"date":"2026.06.02","stock":"-1.72","trade":null,"ind":"1.63"},{"date":"2026.06.01","stock":"2.35","trade":null,"ind":"-1.51"},{"date":"2026.05.29","stock":"-1.92","trade":null,"ind":"-1.81"},{"date":"2026.05.28","stock":"-0.10","trade":null,"ind":"0.80"},{"date":"2026.05.27","stock":"-2.25","trade":null,"ind":"-0.88"},{"date":"2026.05.26","stock":"-1.30","trade":null,"ind":"0.12"},{"date":"2026.05.25","stock":"-1.10","trade":null,"ind":"1.66"},{"date":"2026.05.22","stock":"1.77","trade":null,"ind":"2.30"},{"date":"2026.05.21","stock":"-2.46","trade":null,"ind":"-2.07"},{"date":"2026.05.20","stock":"-3.09","trade":null,"ind":"0.00"},{"date":"2026.05.19","stock":"1.25","trade":null,"ind":"0.26"},{"date":"2026.05.18","stock":"1.08","trade":null,"ind":"-0.20"},{"date":"2026.05.15","stock":"-1.07","trade":null,"ind":"-1.17"},{"date":"2026.05.14","stock":"-2.95","trade":null,"ind":"-2.14"},{"date":"2026.05.13","stock":"-0.35","trade":null,"ind":"1.67"},{"date":"2026.05.12","stock":"-1.95","trade":null,"ind":"-0.47"},{"date":"2026.05.11","stock":"1.11","trade":null,"ind":"2.16"},{"date":"2026.05.08","stock":"1.38","trade":null,"ind":"-0.50"},{"date":"2026.05.07","stock":"0.09","trade":null,"ind":"1.18"}]
戴维医疗,深证成指,医疗器械指数
压力支撑
该股压力位为9.96元，支撑位为9.77元。
[{"text":"\u538b\u529b\u4f4d","value":"9.96","date":1780502400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"9.77","date":1780502400,"color":"0x0b52a1"}]
多空趋势
空头行情中，并且有加速下跌的趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.2资金面打败了26%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：06月04日 20:30
| 机构今日流向(万元) | -770.42 | 机构5日流向(万元) | -2631.54 |
| 机构10日流向(万元) | -5962.72 | 机构20日流向(万元) | -13845.13 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少237.58万股，其中基金净增仓13家，主力净减仓1家，暂未发现中长期投资价值。
截止2025-12-31，共57家主力机构（基金55家，QFII2家），持仓量总计438.07万股，占流通A股3.05%
其中，基金持仓与2025-06-30相比：
增仓：20家 ，增持 164.76万股
减仓：7家 ，减持 25.75万股
新出现在主力名单中：28家 ，持有49.38万股
从主力名单中消失：29家 ，原持有354.15万股
其中，基金持仓与2025-06-30相比：
增仓：20家 ，增持 164.76万股
减仓：7家 ，减持 25.75万股
新出现在主力名单中：28家 ，持有49.38万股
从主力名单中消失：29家 ，原持有354.15万股
消息面诊股
诊断结果：6.6消息面打败了84%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 戴维医疗：截至2026年5月20日公司股东总户数约
2026-05-25 - 戴维医疗主力资金持续净流入，3日共净流入1055.
2026-05-13 - 持续霸榜！宁波A股为何受外资追捧？
2026-05-09 - 2025浙股董秘薪酬图鉴：杭州董秘站稳C位，薪酬涨
2026-05-06 - 戴维医疗2025年全年每10股派0.8元 股权登
2026-04-29 - DeepSeek-V4预览版本正式上线并同步开源
2026-04-24 - 600323，并购整合升级，明起复牌！上海、广东双
2026-04-23 - 戴维医疗主力资金持续净流入，3日共净流入1822.
2026-04-23 - 股东追踪|UBS AG等新进戴维医疗前十大流通股东
2026-04-22 - 财报速递：戴维医疗2026年一季度净利润988.5
2026-04-24
消息列表
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-03 |
| 利好 | 分红转增 | 10派0.8元(含税) | 2026-04-03 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2026-01-29 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-03 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-22 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 1条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：3.5行业面打败了59%的股票
医疗器械行业最新资金流向
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
[{"date":"2026.06.04","price":"-0.27","value":null},{"date":"2026.06.03","price":"0.73","value":null},{"date":"2026.06.02","price":"1.63","value":null},{"date":"2026.06.01","price":"-1.51","value":null},{"date":"2026.05.29","price":"-1.81","value":null},{"date":"2026.05.28","price":"0.80","value":null},{"date":"2026.05.27","price":"-0.88","value":null},{"date":"2026.05.26","price":"0.12","value":null},{"date":"2026.05.25","price":"1.66","value":null},{"date":"2026.05.22","price":"2.30","value":null},{"date":"2026.05.21","price":"-2.07","value":null},{"date":"2026.05.20","price":"0.00","value":null},{"date":"2026.05.19","price":"0.26","value":null},{"date":"2026.05.18","price":"-0.20","value":null},{"date":"2026.05.15","price":"-1.17","value":null},{"date":"2026.05.14","price":"-2.14","value":null},{"date":"2026.05.13","price":"1.67","value":null},{"date":"2026.05.12","price":"-0.47","value":null},{"date":"2026.05.11","price":"2.16","value":null},{"date":"2026.05.08","price":"-0.50","value":null},{"date":"2026.05.07","price":"1.18","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 力诺药包 | 107.53% | 23.39% | 6.1分 |
| 2 | 奕瑞科技 | 57.29% | -9.74% | 6.3分 |
| 3 | 华兰股份 | 31.85% | -2.01% | 5.6分 |
| 4 | 海泰新光 | 21.17% | -2.37% | 6.1分 |
| 5 | 英诺特 | 9.83% | 0.90% | 4.8分 |
| 6 | 东星医疗 | 6.22% | 9.33% | 5.3分 |
| 8 | 南卫股份 | 2.59% | -5.04% | 5.1分 |
| 10 | 正川股份 | 2.20% | -1.25% | 5.8分 |
| 12 | 艾德生物 | 1.59% | 7.65% | 4.8分 |
| 14 | 联影医疗 | 0.30% | -8.66% | 5.5分 |
| 16 | 康拓医疗 | -2.05% | 8.78% | 5.0分 |
| 18 | *ST海利 | -3.68% | -0.29% | 3.5分 |
| 20 | 麦澜德 | -4.41% | -4.23% | 5.6分 |
| 22 | 祥生医疗 | -5.00% | -8.93% | 4.6分 |
| 24 | 瑞迈特 | -5.13% | -3.01% | 5.0分 |
| 26 | 新产业 | -5.46% | -7.86% | 4.7分 |
| 28 | 新华医疗 | -5.82% | -3.62% | 4.5分 |
| 30 | 健帆生物 | -7.41% | -0.63% | 4.4分 |
| 32 | 宝莱特 | -7.74% | -4.55% | 3.9分 |
| 34 | - | -8.20% | 1.92% | 分 |
| 36 | 北芯生命 | -8.52% | -9.45% | 5.0分 |
| 38 | 可孚医疗 | -8.74% | -1.17% | 6.0分 |
| 40 | 华大智造 | -9.12% | -7.98% | 5.2分 |
| 42 | ST迪瑞 | -9.35% | -3.20% | 3.9分 |
| 44 | 济高发展 | -10.13% | -4.05% | 4.8分 |
| 46 | 之江生物 | -10.49% | -20.11% | 4.0分 |
| 48 | - | -10.66% | -1.89% | 分 |
| 50 | 鱼跃医疗 | -10.95% | -2.85% | 5.1分 |
| 52 | 振德医疗 | -11.16% | -1.97% | 5.0分 |
| 54 | 麦克奥迪 | -11.60% | -8.98% | 5.1分 |
| 56 | 康德莱 | -11.98% | -2.04% | 4.7分 |
| 58 | ST凯利 | -12.13% | -10.10% | 4.4分 |
| 60 | 万孚生物 | -12.33% | -7.86% | 3.6分 |
| 62 | 南微医学 | -12.41% | -9.58% | 4.8分 |
| 64 | 康泰医学 | -12.51% | -3.20% | 4.1分 |
| 66 | 迈普医学 | -12.56% | -5.06% | 4.7分 |
| 68 | 万东医疗 | -12.75% | -3.39% | 4.6分 |
| 70 | 圣湘生物 | -13.00% | -6.23% | 4.4分 |
| 72 | 理邦仪器 | -13.54% | -7.23% | 5.1分 |
| 74 | 天益医疗 | -13.58% | -7.87% | 5.1分 |
| 76 | 戴维医疗 | -13.98% | -4.71% | 3.9分 |
| 78 | 春立医疗 | -14.65% | -6.39% | 4.9分 |
| 80 | 尚荣医疗 | -14.73% | -4.14% | 3.8分 |
| 82 | 惠泰医疗 | -14.80% | -5.49% | 5.3分 |
| 84 | 迈瑞医疗 | -15.60% | -5.43% | 4.8分 |
| 86 | 正海生物 | -16.00% | -6.46% | 4.4分 |
| 88 | 天智航 | -16.34% | -6.74% | 4.2分 |
| 90 | 康众医疗 | -17.01% | 1.48% | 4.9分 |
| 92 | 乐心医疗 | -17.26% | -3.66% | 4.1分 |
| 94 | 东方生物 | -17.28% | -5.89% | 3.8分 |
| 96 | 万泰生物 | -17.51% | 1.02% | 4.0分 |
| 98 | 采纳股份 | -17.67% | -9.09% | 4.7分 |
| 100 | 黄山胶囊 | -17.72% | -6.35% | 4.4分 |
| 102 | - | -18.12% | -3.86% | 分 |
| 104 | 楚天科技 | -18.42% | -6.50% | 4.1分 |
| 106 | 欧普康视 | -18.51% | -3.78% | 4.5分 |
| 108 | 爱博医疗 | -18.63% | -2.83% | 4.4分 |
| 110 | 赛科希德 | -19.06% | -6.68% | 4.5分 |
| 112 | 安必平 | -19.15% | -8.60% | 3.9分 |
| 114 | 康为世纪 | -19.48% | -9.67% | 3.9分 |
| 116 | - | -19.70% | -6.53% | 分 |
| 118 | 透景生命 | -20.11% | -7.63% | 3.8分 |
| 120 | 拱东医疗 | -20.30% | -7.41% | 5.0分 |
| 122 | - | -20.82% | -6.62% | 分 |
| 124 | 仁度生物 | -21.01% | -5.59% | 4.5分 |
| 126 | 澳华内镜 | -21.46% | -6.84% | 4.5分 |
| 128 | 伟思医疗 | -21.97% | -11.33% | 4.1分 |
| 130 | 硕世生物 | -22.93% | -10.75% | 4.0分 |
| 132 | 爱朋医疗 | -23.42% | -6.89% | 3.7分 |
| 134 | 奥精医疗 | -24.19% | -7.41% | 3.9分 |
| 136 | 热景生物 | -25.40% | -3.68% | 4.2分 |
| 138 | 爱迪特 | -28.94% | -7.65% | 4.9分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 73/243 ， 78/243。
[{"date":"2026-03-31","value":"0.80","vol":"1.15"},{"date":"2025-12-31","value":"7.25","vol":"2.66"},{"date":"2025-09-30","value":"6.08","vol":"2.97"},{"date":"2025-06-30","value":"4.31","vol":"2.34"},{"date":"2025-03-31","value":"1.91","vol":"1.15"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.80 | 7.25 | 6.08 | 4.31 | 1.91 |
| 行业(%) | 1.15 | 2.66 | 2.97 | 2.34 | 1.15 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"49.92","vol":"52.18"},{"date":"2025-12-31","value":"53.62","vol":"51.61"},{"date":"2025-09-30","value":"56.43","vol":"51.74"},{"date":"2025-06-30","value":"58.40","vol":"52.05"},{"date":"2025-03-31","value":"57.13","vol":"51.74"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
49.92 | 53.62 | 56.43 | 58.40 | 57.13 |
| 行业(%) | 52.18 | 51.61 | 51.74 | 52.05 | 51.74 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 98/243 ， 99/243。
[{"date":"2026-03-31","value":"-6.90","vol":"5.49"},{"date":"2025-12-31","value":"10.82","vol":"1.44"},{"date":"2025-09-30","value":"-2.55","vol":"0.26"},{"date":"2025-06-30","value":"-5.48","vol":"-1.09"},{"date":"2025-03-31","value":"-22.00","vol":"-0.12"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-6.90 | 10.82 | -2.55 | -5.48 | -22.00 |
| 行业(%) | 5.49 | 1.44 | 0.26 | -1.09 | -0.12 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"-56.19","vol":"-16.14"},{"date":"2025-12-31","value":"52.02","vol":"-25.45"},{"date":"2025-09-30","value":"14.71","vol":"-15.37"},{"date":"2025-06-30","value":"9.57","vol":"-18.14"},{"date":"2025-03-31","value":"-40.78","vol":"-2.57"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-56.19 | 52.02 | 14.71 | 9.57 | -40.78 |
| 行业(%) | -16.14 | -25.45 | -15.37 | -18.14 | -2.57 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 67/243 ， 99/243。
[{"date":"2026-03-31","value":"0.08","vol":"0.08"},{"date":"2025-12-31","value":"0.40","vol":"0.35"},{"date":"2025-09-30","value":"0.28","vol":"0.25"},{"date":"2025-06-30","value":"0.18","vol":"0.17"},{"date":"2025-03-31","value":"0.09","vol":"0.08"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.08 | 0.40 | 0.28 | 0.18 | 0.09 |
| 行业(次) | 0.08 | 0.35 | 0.25 | 0.17 | 0.08 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.27","vol":"0.55"},{"date":"2025-12-31","value":"1.41","vol":"2.33"},{"date":"2025-09-30","value":"0.85","vol":"1.66"},{"date":"2025-06-30","value":"0.55","vol":"1.12"},{"date":"2025-03-31","value":"0.28","vol":"0.54"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.27 | 1.41 | 0.85 | 0.55 | 0.28 |
| 行业(次) | 0.55 | 2.33 | 1.66 | 1.12 | 0.54 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"-33.21","vol":"0.09"},{"date":"2025-12-31","value":"38.90","vol":"32.02"},{"date":"2025-09-30","value":"13.29","vol":"14.74"},{"date":"2025-06-30","value":"21.72","vol":"15.54"},{"date":"2025-03-31","value":"-26.61","vol":"4.16"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -33.21 | 38.90 | 13.29 | 21.72 | -26.61 |
| 行业 | 0.09 | 32.02 | 14.74 | 15.54 | 4.16 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.86","vol":"1.59"},{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"2.56","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.86 | - | 2.56 | - |
| 行业 | 0.00 | 1.59 | 0.01 | 1.57 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 73/243 ， 73/243。
[{"date":"2026-03-31","value":"4.48","vol":"6.20"},{"date":"2025-12-31","value":"3.71","vol":"5.29"},{"date":"2025-09-30","value":"4.06","vol":"5.66"},{"date":"2025-06-30","value":"4.17","vol":"5.47"},{"date":"2025-03-31","value":"4.80","vol":"5.80"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
4.48 | 3.71 | 4.06 | 4.17 | 4.80 |
| 行业 | 6.20 | 5.29 | 5.66 | 5.47 | 5.80 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"3.23","vol":"5.06"},{"date":"2025-12-31","value":"2.76","vol":"4.14"},{"date":"2025-09-30","value":"2.95","vol":"4.51"},{"date":"2025-06-30","value":"3.14","vol":"4.35"},{"date":"2025-03-31","value":"3.64","vol":"4.69"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
3.23 | 2.76 | 2.95 | 3.14 | 3.64 |
| 行业 | 5.06 | 4.14 | 4.51 | 4.35 | 4.69 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 82/243 ， 83/243。
[{"date":"2026-03-31","value":"14.34","vol":"21.96"},{"date":"2025-12-31","value":"17.35","vol":"22.90"},{"date":"2025-09-30","value":"15.59","vol":"22.07"},{"date":"2025-06-30","value":"15.72","vol":"22.01"},{"date":"2025-03-31","value":"13.99","vol":"21.02"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
14.34 | 17.35 | 15.59 | 15.72 | 13.99 |
| 行业(%) | 21.96 | 22.90 | 22.07 | 22.01 | 21.02 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.17","vol":"0.39"},{"date":"2025-12-31","value":"0.21","vol":"0.40"},{"date":"2025-09-30","value":"0.18","vol":"0.71"},{"date":"2025-06-30","value":"0.19","vol":"0.58"},{"date":"2025-03-31","value":"0.16","vol":"0.56"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.17 | 0.21 | 0.18 | 0.19 | 0.16 |
| 行业(%) | 0.39 | 0.40 | 0.71 | 0.58 | 0.56 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"0.97","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.48","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.57","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.87","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]